Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cytokine Release Syndrome × lopinavir-ritonavir drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Respiratory Distress Syndrome 1 Pneumonia, Viral 1 Cytokine Release Syndrome 1

Interventions

tocilizumab 1 lopinavir-ritonavir drug combination 1 Piperacillin, Tazobactam Drug Combination 1 Oxygen Inhalation Therapy 1 Neuropsychological Tests 1 Methylprednisolone 1 Magnetic Resonance Spectroscopy 1 Lopinavir 1 Hydroxychloroquine 1 Heparin, Low-Molecular-Weight 1 Contrast Media 1 Azithromycin 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04394182 2022-03-29

ULTRA-COVID

Fundacion GenesisCare

Phase NA Suspended

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡